Growth Metrics

Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests: 2021-2024

Historic Income from Non-Controlling Interests for Adaptive Biotechnologies (ADPT) over the last 4 years, with Dec 2024 value amounting to -$103,000.

  • Adaptive Biotechnologies' Income from Non-Controlling Interests rose 96.15% to -$1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $17,000, marking a year-over-year increase of 116.35%. This contributed to the annual value of -$103,000 for FY2024, which is 90.74% down from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Income from Non-Controlling Interests is -$103,000, which was down 90.74% from -$54,000 recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Income from Non-Controlling Interests ranged from a high of -$19,000 in FY2021 and a low of -$177,000 during FY2022.
  • For the 3-year period, Adaptive Biotechnologies' Income from Non-Controlling Interests averaged around -$111,333, with its median value being -$103,000 (2024).
  • Per our database at Business Quant, Adaptive Biotechnologies' Income from Non-Controlling Interests tumbled by 831.58% in 2022 and then surged by 69.49% in 2023.
  • Adaptive Biotechnologies' Income from Non-Controlling Interests (Yearly) stood at -$19,000 in 2021, then slumped by 831.58% to -$177,000 in 2022, then soared by 69.49% to -$54,000 in 2023, then plummeted by 90.74% to -$103,000 in 2024.